AUM voice prosthesis: A $1 novel modified tracheo-esophageal voice prosthesis for total laryngectomy patients (TEP).

e17549 Background: Patients undergoing total laryngectomy require subsequent voice rehabilitation, which can be done by different modalities. The tracheo-esophageal voice prosthesis provides the clarity of speech and has a high rate of success in terms of acquisition of post laryngectomy speech.In this pilot study we evaluate the functionality of a modified trachea- oesophageal prosthesis to be used in primary and secondary trachea- esophageal puncture in 30 patients of total laryngectomy. Methods: This study was conducted at Health care Global Cancer Centre to evaluate the role of a novel trachea-oesophageal prosthesis for total laryngectomy +/- partial pharyngectomy patients from 2015-2016. 30 patients will be enrolled as an inpatient or outpatient. Post TEP insertion evaluation: Patients, who are undergoing primary TEP insertion, will be evaluated for speech/ voice interval of 6weeks, 12 weeks and 6 months. Objective assessment of speech Assessment of the incidence of TEP leak clinically after a test fluid feed. Through the prosthesis (intra TEP leak) Around the TEP leak (peri TEP leak) Assessment of the extrusion rate of the TEP device Assessment of the complication rate associated with the procedure/TEP Results: On objective assemsmsent of speech, all patients (100%) used prosthesis were able able to phonate and communicate using intelligible speech. 10% patients developed intra TEP leak immediately after insertion of prosthesis, 6% within 3 months of insertion, & 3% developed peri tep leak. All patients were immedaitely given a repalcement prosthesis and leaks corrected. Extrusion was seen in 3% of the patients. None reported any complications. Conclusions: Aum voice prosthesis is a excellent and affrodable tracheo oesophageal prosthetic device to enable and empower patients speeech rehabilitation. Clinical trial information: NCT03039465.